NCT01403974View on ClinicalTrials.gov

Phase I Trial of BI 836845 for Various Solid Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

July 19, 2011

Primary Completion Date

July 8, 2015

Study Completion Date

December 23, 2015

Conditions
Neoplasms
Interventions
DRUG

BI 836845

Intravenous infusion once every week

Trial Locations (3)

404

China Medical University Hospital, Taichung

10002

National Taiwan University Hospital, Taipei

70403

NCKUH, Tainan City

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY